DUBLIN--(BUSINESS WIRE)--The "Global Parkinson's Disease Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
This report provides Parkinson's Disease epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.
The research provides population data to characterize Parkinson's Disease patients, history of the disease at the population level (Parkinson's Disease prevalence, Parkinson's Disease incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.
Research scope:
- Parkinson's Disease patient flow: Parkinson's Disease prevalence, diagnosed, and drug-treated patients
- Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries
- Demographics: Parkinson's Disease patients by age group, gender
- Forecast: Parkinson's Disease epidemiology forecast to 2035
The data from this research will help executives:
- Establish basis for Parkinson's Disease market sizing, assessing market potential, and developing drug forecast models
- Identify Parkinson's Disease patients segments through age groups, gender, and disease sub-types
- Develop Parkinson's Disease population-based health management frameworks
- Evaluate Parkinson's Disease market opportunities, identify target patient population
- Align marketing decisions with the Parkinson's Disease target population
- Communicate leadership and health authorities about your Parkinson's Disease target patient population
Key Topics Covered:
1. Research Methodology
2. Parkinson's Disease Patients Definition
3. US Parkinson's Disease Epidemiology and Patient Flow
4. Germany Parkinson's Disease Epidemiology and Patient Flow
5. France Parkinson's Disease Epidemiology and Patient Flow
6. Italy Parkinson's Disease Epidemiology and Patient Flow
7. Spain Parkinson's Disease Epidemiology and Patient Flow
8. UK Parkinson's Disease Epidemiology and Patient Flow
9. Europe Parkinson's Disease Epidemiology and Patient Flow
10. Japan Parkinson's Disease Epidemiology and Patient Flow
11. Global Parkinson's Disease Epidemiology and Patient Flow
12. Sources
For more information about this report visit https://www.researchandmarkets.com/r/c1veb4
